PYRIDINDERIVATE

European patent · EP0998459 · Deleted

Register entry

Publication number
EP0998459
Application number
EP98941308
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 9, 1998
Published
May 10, 2000
Granted
Apr 23, 2008
Deleted
Jul 31, 2011
Reason
Annual fee unpaid
IPC classes
C07D 213/00 (2006.01)
Priority
US 891691 11.07.1997
US 890689 11.07.1997
PCT application
PCT/EP1998/004266 09.07.1998
PCT publication
WO1999/002497 21.01.1999
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 22, 2012

    Deleted, fee unpaid

    Published in Swissreg on 22.02.2012

  2. Aug 5, 2008

    Transferred

    Owner
    Novartis AG, Lichtstrasse 35, 4056 Basel, Sibia Neurosciences, Inc., Suite 300,, 505 Coast Boulevard South, La Jolla, CA 92037-4641, USA → Novartis AG, Lichtstrasse 35, 4056 Basel, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, USA

    Published in Swissreg on 05.08.2008

  3. May 15, 2008

    Granted

    Published in +pat+ No 9 in 2008

Parties

Inventor

ALLGEIER, Hans

D-79541 Lörrach, DE

AUBERSON, Yves

CH-4123 Allschwil

BIOLLAZ, Michel

CH-4102 Binningen

COSFORD, Nicholas, David

San Diego, CA 92122, US

GASPARINI, Fabrizio

CH-4415 Lausen

HECKENDORN, Roland

CH-4144 Arlesheim

JOHNSON, Edwin, Carl

San Diego, CA 92129, US

KUHN, Rainer

D-79540 Lörrach, DE

VARNEY, Mark, Andrew

San Diego, CA 92129, US

VELICELEBI, Gönül

San Diego, CA 92130, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.